ANS Monitoring That Gives Medical
Professionals Real Answers
Objectively Quantify Parasympathetic
and Sympathetic Activity.
Physio PS monitors both Parasympathetic and Sympathetic branches independently, simultaneously, and quantitatively, providing objective insight into autonomic function through a non-invasive, 15-minute test.
See the technology live in a 60-minute
virtual session.
• FDA 510(k) Cleared
• Peer-Reviewed Science
• HIPAA-Aligned
• Proactive Healthcare Starts Here
What Happens During the Test
ANS Monitoring That Gives Medical
Professionals Real Answers
What Happens During the Test
See the technology live in a 60-minute virtual session.

— For Your Practice
Many autonomic patients spend a decade seeing four or five doctors who focus only on symptoms. Be the practice that identifies the underlying cause, and the provider patients will travel to see.
Differentiation
The only solution on the market that measures both parasympathetic and sympathetic branches independently, simultaneously and quantitatively.
Reputation
Become the regional destination for a diagnosis nobody else in your area offers.
Referrals
Colleagues send you the cases they cannot resolve, and those patients come back for everything else.
Revenue
A new, supportable revenue line backed by fundable billing codes, without adding staff.
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research
— For Your Practice
Many autonomic patients spend a decade seeing four or five doctors who focus only on symptoms. Be the practice that identifies the underlying cause, and the provider patients will travel to see.
Differentiation
The only solution on the market that measures both parasympathetic and sympathetic branches independently, simultaneously and quantitatively.
Reputation
Become the regional destination for a diagnosis nobody else in your area offers.
Referrals
Colleagues send you the cases they cannot resolve, and those patients come back for everything else.
Revenue
A new, supportable revenue line backed by fundable billing codes, without adding staff.
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research
— Physician and Patient Voices
Medical professionals using the technology in practice, and a patient who found an answer through it.
— Physician and Patient Voices
Medical professionals using the technology in practice, and a patient who found an answer through it.
— Your Specialty
ANS Monitoring for Sports Performance
Assess the autonomic contribution to dysrhythmia, syncope, and heart failure, with both branches of the autonomic nervous system measured independently to provide objective clinical insights.
Roughly 80% of atrial dysrhythmias involve the P&S systems; monitoring specifies which branch, rather than treating all of them as cardiogenic
Congestive heart failure shows a rising sympathetic baseline up to four days before the 3% weight-gain indicator
Vasovagal, neurogenic and cardiogenic syncope separate on the stand response, where tilt-table struggles to differentiate
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research ✓ In Business Since 2019
— Your Specialty
ANS Monitoring for Sports Performance
Assess the autonomic contribution to dysrhythmia, syncope, and heart failure, with both branches of the autonomic nervous system measured independently to provide objective clinical insights.
Roughly 80% of atrial dysrhythmias involve the P&S systems; monitoring specifies which branch, rather than treating all of them as cardiogenic
Congestive heart failure shows a rising sympathetic baseline up to four days before the 3% weight-gain indicator
Vasovagal, neurogenic and cardiogenic syncope separate on the stand response, where tilt-table struggles to differentiate
— The Unsolved Cases

The POTS case that bounced between cardiology and psychiatry. The Long-COVID or PTSD patient whose labs come back normal while the symptoms stay real. The patient who has already seen everyone and tells you so.
Those visits cost time, and they leave without an answer or a follow-up. Autonomic dysfunction affects an estimated 90 million people, and most of it is never measured. When you can measure it, the unsolved case becomes a solved one, and a referral source.
POTS, differentiated from syncope by the direction of the sympathetic response to standing
Long-COVID, with the autonomic component quantified when standard testing reads normal
PTSD, where the quality-of-life symptoms are autonomic and therefore measurable
PTSD, where the quality-of-life symptoms are autonomic and therefore measurable
Forty-three conditions in total, each with the parasympathetic or sympathetic pattern behind it

— The Unsolved Cases
The POTS case that bounced between cardiology and psychiatry. The Long-COVID or PTSD patient whose labs come back normal while the symptoms stay real. The patient who has already seen everyone and tells you so.
Those visits cost time, and they leave without an answer or a follow-up. Autonomic dysfunction affects an estimated 90 million people, and most of it is never measured. When you can measure it, the unsolved case becomes a solved one, and a referral source.
POTS, differentiated from syncope by the direction of the sympathetic response to standing
Long-COVID, with the autonomic component quantified when standard testing reads normal
PTSD, where the quality-of-life symptoms are autonomic and therefore measurable
Forty-three conditions in total, each with the parasympathetic or sympathetic pattern behind it

FDA cleared to U.S. medical device standards.
In business since 2019, with patented technology.
Both ANS branches measured independently and simultaneously.
— The technology
Most autonomic monitoring only measures the sympathetic nervous system or heart rate variability. Physio PS monitors both Parasympathetic and Sympathetic branches independently, simultaneously, and quantitatively, using algorithmic measurement of LFa and RFa.
Independent P&S monitoring. Simultaneously and independently quantify Parasympathetic (RFa) and Sympathetic (LFa) activity: dual-branch precision no other technology on the market achieves.
FDA 510(k) cleared. A regulatory-cleared medical device backed by peer-reviewed clinical research and validated diagnostic algorithms.
Portable and deployable. Battery-powered, compact design for clinics, in-home care, sports medicine, field deployment and mobile diagnostics.
Revenue generator. Supported by fundable billing codes, with multiple purchase options.

Dual-branch measurement validated by Colombo et
al. Clinical Autonomic Dysfunction: Measurement,
Indications, Therapies, Springer.

— The technology
Most autonomic monitoring only measures the sympathetic nervous system or heart rate variability. Physio PS monitors both Parasympathetic and Sympathetic branches independently, simultaneously, and quantitatively, using algorithmic measurement of LFa and RFa.
Independent P&S monitoring. Simultaneously and independently quantify Parasympathetic (RFa) and Sympathetic (LFa) activity: dual-branch precision no other technology on the market achieves.
FDA 510(k) cleared. A regulatory-cleared medical device backed by peer-reviewed clinical research and validated diagnostic algorithms.
Portable and deployable. Battery-powered, compact design for clinics, in-home care, sports medicine, field deployment and mobile diagnostics.
Revenue generator. Supported by fundable billing codes, with multiple purchase options.
Dual-branch measurement validated by Colombo et
al. Clinical Autonomic Dysfunction: Measurement,
Indications, Therapies, Springer.
— Clinical impact
ANS testing provides physicians with actionable data across an unprecedented spectrum of diseases and disorders, many of which go undetected by standard diagnostic methods.

— Clinical impact
ANS testing provides physicians with actionable data across an unprecedented spectrum of diseases and disorders, many of which go undetected by standard diagnostic methods.
ANS testing provides measurements, not a diagnosis. Medical professionals interpret the results alongside the patient's history, examination, and other findings.
— Solutions
From a desktop unit in a clinic room to a research license for a university lab, every configuration runs the same proprietary software and the same automated reporting.
— Solutions
From a desktop unit in a clinic room to a research license for a university lab, every configuration runs the same proprietary software and the same automated reporting.

Clinical Monitoring Unit (CMU)
The Clinical Monitoring Unit is a desktop-based ANS monitoring system designed for any clinic environment. FDA 510(k) cleared and supported by fundable billing codes, the CMU gives your practice a deeper look at autonomic function, while opening a new, supportable revenue stream.

ANS Monitoring Integration
ANS monitoring integration from Physio PS helps medical practices add autonomic function testing to existing treatment protocols, with automated workflows, patient-facing reports, and clinical guidance included. No complex setup, no steep learning curve, and potential for cash-based add-on services.

Remote Monitoring Unit (RMU)
The Remote Monitoring Unit is a portable, tablet-based ANS monitoring system built for in-home care providers and sports medicine practitioners. Battery-powered and compact, it brings the same complete autonomic function testing to any setting, without being tethered to a clinic.

Clinical Monitoring Unit (CMU)
The Clinical Monitoring Unit is a desktop-based ANS monitoring system designed for any clinic environment. FDA 510(k) cleared and supported by fundable billing codes, the CMU gives your practice a deeper look at autonomic function, while opening a new, supportable revenue stream.

ANS Monitoring Integration
ANS monitoring integration from Physio PS helps medical practices add autonomic function testing to existing treatment protocols, with automated workflows, patient-facing reports, and clinical guidance included. No complex setup, no steep learning curve, and potential for cash-based add-on services.

Remote Monitoring Unit (RMU)
The Remote Monitoring Unit is a portable, tablet-based ANS monitoring system built for in-home care providers and sports medicine practitioners. Battery-powered and compact, it brings the same complete autonomic function testing to any setting, without being tethered to a clinic.

Portable Autonomic Lab (PAL)
The Portable Autonomic Lab is a laptop-based ANS monitoring solution built for the medical professional who moves between facilities or works in the field. Multiple power options and a compact form factor mean you get complete autonomic function testing wherever the work takes you.

Research Software Program (Physio PS 4.0)
Physio PS 4.0 is a research-grade ANS software program available to approved researchers on a one-year renewable license. Built on the same platform trusted by physicians worldwide, it gives research teams the autonomic monitoring tools needed for rigorous, publishable work.

Portable Autonomic Lab (PAL)
The Portable Autonomic Lab is a laptop-based ANS monitoring solution built for the medical professional who moves between facilities or works in the field. Multiple power options and a compact form factor mean you get complete autonomic function testing wherever the work takes you.

Research Software Program (Physio PS 4.0)
Physio PS 4.0 is a research-grade ANS software program available to approved researchers on a one-year renewable license. Built on the same platform trusted by physicians worldwide, it gives research teams the autonomic monitoring tools needed for rigorous, publishable work.
— Return on Investment
The assessment is non-invasive and supported by fundable billing codes. It integrates into existing clinical protocols rather than requiring major workflow changes, making implementation manageable through focused staff training and practice integration.
Veteran-owned discounts for qualifying practices
Financing options with low monthly payments, so the equipment does not sit against your capital budget
Fundable billing codes that add a documented revenue line without adding staff burden
Cash-based add-on services: biofeedback and recovery coaching, preventive screenings, performance packages
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research
✓ In Business Since 2019

— Return on Investment

The assessment is non-invasive and supported by fundable billing codes. It integrates into existing clinical protocols rather than requiring major workflow changes, making implementation manageable through focused staff training and practice integration.
Veteran-owned discounts for qualifying practices
Financing options with low monthly payments, so the equipment does not sit against your capital budget
Fundable billing codes that add a documented revenue line without adding staff burden
Cash-based add-on services: biofeedback and recovery coaching, preventive screenings, performance packages
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research ✓ In Business Since 2019
— About Physio PS, Inc.
Co-founder Steve O'Leary believed he was in good health until routine ANS monitoring revealed he had Cardiac Autonomic Neuropathy. That diagnosis, he says, saved his life.
Today, Physio PS brings together doctors, researchers, and clinical support staff united by one mission: to improve how people understand and respond to imbalances in the autonomic nervous system.

The only solution on the market that measures both parasympathetic and
sympathetic branches independently, simultaneously, and quantitatively.
— About Physio PS, Inc.

Co-founder Steve O'Leary believed he was in good health until routine ANS monitoring revealed he had Cardiac Autonomic Neuropathy. That diagnosis, he says, saved his life.
Today, Physio PS brings together doctors, researchers, and clinical support staff united by one mission: to improve how people understand and respond to imbalances in the autonomic nervous system.
— Where it is used
Veterans exposed to burn pits in Afghanistan and Iraq carry toxic burdens that mainstream medicine can't diagnose with standard tools. ANS testing gives medical professionals the diagnostic intelligence to treat, not just manage, those invisible wounds.
3.5M+
Veterans exposed to burn pits
86%
Report chronic health issues
Clinical focus: burn-pit and deployment toxicity · TBI · PTSD vagal-tone restoration.

— Target markets
— Where it is used

Veterans exposed to burn pits in Afghanistan and Iraq carry toxic burdens that mainstream medicine can't diagnose with standard tools. ANS testing gives medical professionals the diagnostic intelligence to treat, not just manage, those invisible wounds.
3.5M+
Veterans exposed to burn pits
86%
Report chronic health issues
Clinical focus: burn-pit and deployment toxicity · TBI · PTSD vagal-tone restoration.

— Distribution Partners
Bring ANS monitoring to the clinics in your territory, with an FDA-cleared, patented platform that medical professionals buy for results they can measure.
Five solutions to offer: the CMU, RMU and PAL systems, practice integration and research licensing
An easier purchase for your clinics: fundable billing codes, financing options and low monthly payments
Veteran-owned discounts for qualifying practices
Training and certification included with every system, so the clinics you sign are ready from day one
A clear point of difference: the only solution on the market that measures both parasympathetic and sympathetic branches independently, simultaneously and quantitatively
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research ✓ In Business Since 2019

— Distribution Partners
Bring ANS monitoring to the clinics in your territory, with an FDA-cleared, patented platform that medical professionals buy for results they can measure.

Five solutions to offer: the CMU, RMU and PAL systems, practice integration and research licensing
An easier purchase for your clinics: fundable billing codes, financing options and low monthly payments
Veteran-owned discounts for qualifying practices
Training and certification included with every system, so the clinics you sign are ready from day one
A clear point of difference: the only solution on the market that measures both parasympathetic and sympathetic branches independently, simultaneously and quantitatively
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research ✓ In Business Since 2019
— FAQ
Straight answers on time, cost, clearance and fit.
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research ✓ In Business Since 2019
A complete autonomic assessment is non-invasive and takes 15 minutes. It is fully automated, and the qualitative, quantitative and graphical reports are delivered without manual interpretation.
Yes. The platform is FDA 510(k) cleared to U.S. medical device standards, patented, and backed by published research.
The Clinical Monitoring Unit is supported by fundable billing codes. For the other systems, ask about billing code applicability during your demo. Financing options, low monthly payments and veteran-owned discounts are available to qualifying practices.
No. Testing integrates with your existing treatment protocols with no workflow overhaul and no tilt table required. Training and certification are included, so your team is ready from day one.
It is the only solution on the market that measures both parasympathetic and sympathetic branches independently, simultaneously and quantitatively, rather than reporting one blended figure.
The CMU is a desktop system for clinics, the RMU is tablet-based and battery-powered for home care and sports medicine, and the PAL is laptop-based for medical professionals who move between facilities. A free demo is the quickest way to find the right configuration.
Tell us about your territory and the clinics you work with through the distributor enquiry form, or call 603-287-1817, and the team will follow up to discuss distribution.
— FAQ
Straight answers on time, cost, clearance and fit.
A complete autonomic assessment is non-invasive and takes 15 minutes. It is fully automated, and the qualitative, quantitative and graphical reports are delivered without manual interpretation.
Yes. The platform is FDA 510(k) cleared to U.S. medical device standards, patented, and backed by published research.
The Clinical Monitoring Unit is supported by fundable billing codes. For the other systems, ask about billing code applicability during your demo. Financing options, low monthly payments and veteran-owned discounts are available to qualifying practices.
No. Testing integrates with your existing treatment protocols with no workflow overhaul and no tilt table required. Training and certification are included, so your team is ready from day one.
It is the only solution on the market that measures both parasympathetic and sympathetic branches independently, simultaneously and quantitatively, rather than reporting one blended figure.
The CMU is a desktop system for clinics, the RMU is tablet-based and battery-powered for home care and sports medicine, and the PAL is laptop-based for medical professionals who move between facilities. A free demo is the quickest way to find the right configuration.
Tell us about your territory and the clinics you work with through the distributor enquiry form, or call 603-287-1817, and the team will follow up to discuss distribution.
See how ANS testing can transform your practice, improve patient outcomes, and open new revenue streams. A 60-minute virtual session with an autonomic expert.
✓ FDA 510(k) Cleared ✓ Patented Technology ✓ Backed by Published Research ✓ In Business Since 2019
See how ANS testing can transform your practice, improve patient outcomes, and open new revenue streams. A 60-minute virtual session with an autonomic expert.
— Next Step
— Next Step
Site
Who We Serve
Journal
Contact
603-287-1817
80 Nashua Rd, Building C, Unit G1, Londonderry, NH 03053
© 2026 Physio PS, Inc. All rights reserved. FDA 510(k) cleared · Patented · Established 2019.
Hours available on request, ask during your demo.
Copyright 2026 Physio PS, Inc. All Rights Reserved.
The material and information provided by Physio PS is for general information purposes only. You should not rely upon this material or information for basis of making healthcare, treatment, or diagnosis decisions. While Physio PS strives to provide the most correct and up-to-date information and data, Physio PS makes no representations or warranties of any kind, expressed or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the information, products, services, or related graphics contained. Any reliance placed on such material is therefore strictly at your own risk. Reporting Information is supplied under license by NCRC LLC. * ‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.
Site
Who We Serve
Journal
Contact
603-287-1817
80 Nashua Rd, Building C, Unit G1, Londonderry, NH 03053
© 2026 Physio PS, Inc. All rights reserved.
FDA 510(k) cleared · Patented · Established 2019.
Hours available on request, ask during your demo.
Copyright 2026 Physio PS, Inc. All Rights Reserved.
The material and information provided by Physio PS is for general information purposes only. You should not rely upon this material or information for basis of making healthcare, treatment, or diagnosis decisions. While Physio PS strives to provide the most correct and up-to-date information and data, Physio PS makes no representations or warranties of any kind, expressed or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the information, products, services, or related graphics contained. Any reliance placed on such material is therefore strictly at your own risk. Reporting Information is supplied under license by NCRC LLC. * ‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.